Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Pharmadrug Inc (2): Pharmadrug to issue $414,523 in debenture units | 1 | Stockwatch | ||
Do | PharmaDrug Inc.: PharmaDrug Announces Proposed Issuance of Debenture Units | 312 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
Do | Pharmadrug Inc (2): Pharmadrug completes PD-001 stability study | 2 | Stockwatch | ||
Do | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases | 153 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
20.09. | PharmaDrug Subsidiary Begins Prep Work For Clinical Trial Of PD-001 For Viral Infectious Diseases | 4 | The Deep Dive | ||
19.09. | Pharmather Holdings Ltd: Pharmadrug begins start-up work for PD-001 study | 2 | Stockwatch | ||
19.09. | Pharmadrug Inc (2): Pharmadrug begins start-up work for PD-001 study | 2 | Stockwatch | ||
19.09. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases | 227 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research,... ► Artikel lesen | |
28.08. | Pharmadrug Inc (2): Pharmadrug details plans for cepharanthine development | 2 | Stockwatch | ||
28.08. | Pharmather Holdings Ltd: Pharmadrug details plans for cepharanthine development | 3 | Stockwatch | ||
28.08. | PharmaDrug Subsidiary To Focus Development Of PD-001 On Viral Infectious Diseases | 1 | The Deep Dive | ||
28.08. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases | 386 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
21.08. | PharmaDrug: Cepharanthine Identified For Potential To Bind To Monkeypox Proteins In Independent Screening | 3 | The Deep Dive | ||
21.08. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins | 426 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
19.08. | Bullish Monday For Marijuana Stocks - Leafbuyer Techs, Pharmadrug Among Top Gainers | 2 | Benzinga.com | ||
19.08. | Pharmather Holdings Ltd: Pharmadrug, Pharmather get OK for PD-001 human trial | 1 | Stockwatch | ||
19.08. | Pharmadrug Inc (2): Pharmadrug, Pharmather get OK for PD-001 human trial | 2 | Stockwatch | ||
19.08. | PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial | 1 | The Deep Dive | ||
19.08. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine | 352 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
23.05. | Pharmadrug Inc (2): Pharmadrug's SecureDose signs LOI with licensed dealer | 4 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 5,075 | -0,88 % | Unglaubliche Prognose für Montag setzt Aurora Cannabis Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
CANOPY GROWTH | 4,450 | -0,89 % | Unglaubliche Prognose für Montag setzt Canopy Growth Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
TILRAY BRANDS | 1,511 | -0,49 % | Unglaubliche Prognose für Montag setzt Tilray Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
INNOCAN PHARMA | 0,151 | +2,38 % | Unglaubliche Prognose für Montag setzt Innocan Pharma Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
TAAT GLOBAL ALTERNATIVES | 0,182 | +19,34 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
DERMAPHARM | 31,050 | -0,48 % | EQS-DD: Dermapharm Holding SE: Susanne Gertrud Pia Lanz, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
23.10.2024 / 16:32... ► Artikel lesen | |
CRONOS GROUP | 1,886 | -5,65 % | Cronos Group Inc: Cronos Group to hold Q3 2024 results call Nov. 12 | ||
SYNBIOTIC | 6,280 | +2,61 % | SYNBIOTIC SE: Online-Präsentation für Investoren am 05.11.2024 | SYNBIOTIC SE ist ein führendes deutsches börsennotiertes Unternehmen, das sich auf Hanf, Cannabis und Cannabinoide konzentriert. Das Unternehmen verfolgt eine paneuropäische Buy-and-Build-Strategie... ► Artikel lesen | |
VIATRIS | 10,710 | -0,09 % | Earnings Preview: What To Expect From Viatris' Report | ||
TRANSCANNA | 0,017 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
ORGANIGRAM | 1,600 | -0,12 % | Paolo De Luca Sells 12,014 Shares of Organigram Holdings Inc. (TSE:OGI) Stock | ||
CRESCO LABS | 1,406 | -0,21 % | Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 9,450 | -0,21 % | Should You Buy Canopy Growth Stock or Green Thumb Stock Today? | ||
SNDL | 1,939 | -0,21 % | SNDL Inc.: SNDL Successfully Completes Privatization of Nova Cannabis Inc. and Welcomes New Director | CALGARY, AB, Oct. 21, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL") and Nova Cannabis Inc. (TSX: NOVC) ("Nova") are pleased to announce the closing of the previously announced plan of arrangement... ► Artikel lesen |